- Telehealth service focused on medication risk and disease management of the chronically ill patient.
- Ready to market solution with high growth and potential.
- $40B in Medicare funding approved to pay for this service – of which only 1.5% was accessed in 2019.
We partner with physicians, hospitals and health insurance companies to connect high-risk patients with our pharmacists via secure telehealth technology in between their doctor visits to provide Chronic Care Management (CCM). CCM helps prevent dangerous medication-related problems, lower costs and improve the overall life of the patient. Patients and physicians have 24/7 access to our pharmacists for medication related consults via our proprietary telehealth platform.
The current market is drastically underserved. Last year only 1.5% of the $40B in Medicare funds designated to pay for this service were utilized. With our scalable service we believe we can reach over 600,000 patients by our 5th year and generate a potential of $450 million in revenue (this cannot be guaranteed). With this model, we hope to be an attractive acquisition target by a major US healthcare company or private equity firm, yielding significant return on investment.